Actions of BAX on mitochondrial channel activity and on synaptic transmission

Antioxidants and Redox Signaling

Volumn 7, Issue 9-10, 2005, Pages 1092-1100

  Jonas, Elizabeth A ^a,c   Hardwick, J Marie ^b,c   Kaczmarek, Leonard K ^a,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c MARINE BIOLOGICAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BH3 PROTEIN; NEUROTRANSMITTER; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL;

APOPTOSIS; ARTICLE; CELL DEATH; CELL ULTRASTRUCTURE; CHANNEL GATING; CONTROLLED STUDY; MEMBRANE CHANNEL; MEMBRANE TRANSPORT; MITOCHONDRIAL MEMBRANE; NERVE CELL NECROSIS; NERVE ENDING; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; NONHUMAN; PATCH CLAMP; POROSITY; PRIORITY JOURNAL; PROTEIN FUNCTION; SQUID; SYNAPTIC TRANSMISSION;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CELL MEMBRANE; ELECTROPHYSIOLOGY; INTRACELLULAR MEMBRANES; LIPOSOMES; LOLIGO; MITOCHONDRIA; MULTIGENE FAMILY; NEUROTRANSMITTER AGENTS; PATCH-CLAMP TECHNIQUES; PEPTIDES; PRESYNAPTIC TERMINALS; PROTEIN STRUCTURE, TERTIARY; SYNAPSES; SYNAPTIC TRANSMISSION; TIME FACTORS;

CEPHALOPODA;

EID: 24144493694     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2005.7.1092     Document Type: Article

References (46)

1. Antonsson B, Conti F, Ciavatta A, Montessuit S, Lewis S, Martinou I, Bernasconi L, Bernard A, Mermod JJ, Mazzei G, Maundrell K, Gambale F, Sadoul R, and Martinou JC. Inhibition of Bax channel-forming activity by Bcl-2. Science 277: 370-372, 1997.
2. Antonsson B, Montessuit S, Lauper S, Eskes R, and Martinou JC. Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c c release from mitochondria. Biochemical J 345: 271-278, 2000.
3. Banasiak KJ, Xia Y, and Haddad GG. Mechanisms underlying hypoxia-induced neuronal apoptosis. Prog Neurobiol 62: 215-249, 2000.
4. Chapman PF, White GL, Jones MW, Cooper-Blacketer D, Marshall VJ, Irizarry M, Younkin L, Good MA, Bliss TV, Hyman BT, Younkin SG, and Hsiao KK. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat Neurosci 2: 271-276, 1999.
5. Cheng EH, Wei MC, Weiler S, Flavell RA, Mak TW, Lindsten T, and Korsmeyer SJ. BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol Cell 8: 705-711, 2001.
6. L through caspase interaction. Proc Natl Acad Sci USA 95: 554-559, 1998.
7. Cory S, Huang DC, and Adams JM. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 22: 8590-8607, 2003.
8. Eskes R, Desagher S, Antonsson B, and Martinou JC. Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol Cell Biol 20: 929-935, 2000.
9. Fannjiang Y, Kim CH, Huganir RL, Zou S, Lindsten T, Thompson CB, Mito T, Traystman RJ, Larsen T, Griffin DE, Mandir AS, Dawson TM, Dike S, Sappington AL, Kerr DA, Jonas EA, Kaczmarek LK, and Hardwick JM. BAK alters neuronal excitability and can switch from anti- to pro-death function during postnatal development. Dev Cell 4: 575-585, 2003.
10. Fujita N, Nagahashi A, Nagashima K, Rokudai S, and Tsuruo T. Acceleration of apoptotic cell death after the cleavage of Bcl-xL protein by caspase-3-like proteases. Oncogene 17: 1295-1304, 1998.
11. Green DR and Kroemer G. The pathophysiology of mitochondrial cell death. Science 305: 626-629, 2004.
12. Hsu YT and Youle RJ. Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations. J Biol Chem 273: 10777-10783, 1998.
13. Jonas EA, Knox RJ, and Kaczmarek LK. Giga-ohm seals on intracellular membranes: a technique for studying intracellular ion channels in intact cells. Neuron 19: 7-13, 1997.
14. Jonas EA, Buchanan J, and Kaczmarek LK. Prolonged activation of mitochondrial conductances during synaptic transmission. Science 286: 1347-1350, 1999.
15. Jonas EA, Hoit D, Hickman JA, Brandt TA, Polster BM, Fannjiang Y, McCarthy E, Montanez MK, Hardwick JM, and Kaczmarek LK. Modulation of synaptic transmission by the BCL-2 family protein BCL-xL. J Neurosci 23: 8423-8431, 2003.
16. Jonas EA, Hickman JA, Chachar M, Polster BM, Brandt TA, Fannjiang Y, Ivanovska I, Basañez G, Kinnally KW, Zimmerberg J, Hardwick JM, and Kaczmarek LK. Proapoptotic N-truncated BCL-xL protein activates endogenous mitochondrial channels in living synaptic terminals. Proc Natl Acad Sci U S A 101: 13590-13595, 2004.
17. Kelekar A and Thompson CB. Bcl-2-family proteins: the role of the BH3 domain in apoptosis. Trends Cell Biol 8: 324-330, 1998.
18. Kroemer G and Reed JC. Mitochondrial control of cell death. Nat Med 6: 513-519, 2000.
19. Lewis J, Oyler GA, Ueno K, Fannjiang Y, Chau BN, Vornov J, Korsmeyer SJ, Zou S, and Hardwick JM. Inhibition of virus-induced neuronal apoptosis by Bax. Nat Med 5: 832-835, 1999.
20. Li JY, Plomann M, and Brundin P. Huntington's disease: a synaptopathy? Trends Mol Med 9: 414-420, 2003.
21. Lim KC, Lim ST, and Federoff HJ. Neurotrophin secretory pathways and synaptic plasticity. Neurobiol Aging 24: 1135-1145, 2003.
22. Lindsten T, Ross AJ, King A, Zong WX, Rathmell JC, Shiels HA, Ulrich E, Waymire KG, Mahar P, Frauwirth K, Chen Y, Wei M, Eng VM, Adelman DM, Simon MC, Ma A, Golden JA, Evan G, Korsmeyer SJ, MacGregor GR, and Thompson CB. The combined functions of proapoptotic Bcl-2 family members Bak and Bax are essential for normal development of multiple tissues. Mol Cell 6: 1389-1399, 2000.
23. Marzo I, Brenner C, Zamzami N, Jurgensmeier JM, Susin SA, Vieira HL, Prevost MC, Xie Z, Matsuyama S, Reed JC, and Kroemer G. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 281: 2027-2031, 1998.
24. Middleton G and Davies AM. Populations of NGF-dependent neurones differ in their requirement for BAX to undergo apoptosis in the absence of NGF/TrkA signalling in vivo. Development 128: 4715-4728, 2001.
25. L forms an ion channel in synthetic lipid membranes. Nature 385: 353-357, 1997.
26. Morgan JR, Prasad K, Jin S, Augustine GJ, and Lafer EM. Uncoating of clathrin-coated vesicles in presynaptic terminals: roles for Hsc70 and auxilin. Neuron 32: 289-300, 2001.
27. Nakagawa T and Yuan J. Cross-talk between two cysteine protease families: activation of caspase-12 by calpain in apoptosis. J Cell Biol 150: 887-894, 2000.
28. Pavlov EV, Priault M, Pietkiewicz D, Cheng EH, Antonsson B, Manon S, Korsmeyer SJ, Mannella CA, and Kinnally KW. A novel, high conductance channel of mitochondria linked to apoptosis in mammalian cells and Bax expression in yeast. J Cell Biol 155: 725-731, 2001.
29. Polster BM, Kinnally KW, and Fiskum G. BH3 death domain peptide induces cell type-selective mitochondrial outer membrane permeability. J Biol Chem 276: 37887-37894, 2001.
30. Roucou X, Montessuit S, Antonsson B, and Martinou JC. Bax oligomerization in mitochondrial membranes requires tBid (caspase-8-cleaved Bid) and a mitochondrial protein. Biochem J 368: 915-921, 2002.
31. Schendel SL, Montal M, and Reed JC. Bcl-2 family proteins as ion-channels. Cell Death Differ 5: 372-380, 1998.
32. Schlesinger PH, Gross A, Yin XM, Yamamoto K, Saito M, Waksman G, and Korsmeyer SJ. Comparison of the ion channel characteristics of pro-apoptotic BAX and antiapoptotic BCL-2. Proc Natl Acad Sci U S A 94: 11357-11362, 1997.
33. Seo SY, Chen YB, Ivanovska I, Ranger AM, Hong SJ, Dawson VL, Korsmeyer SJ, Bellows DS, Fannjiang Y, and Hardwick JM. BAD is a pro-survival factor prior to activation of its pro-apoptotic function. J Biol Chem 279: 42240-42249, 2004.
34. Suzuki M, Youle RJ, and Tjandra N. Structure of Bax: coregulation of dimer formation and intracellular localization. Cell 103: 645-654, 2000.
35. Swandulla D, Hans M, Zipser K, and Augustine GJ. Role of residual calcium in synaptic depression and posttetanic potentiation: fast and slow calcium signaling in nerve terminals. Neuron 7: 915-926, 1991.
36. Vander Heiden MG, and Thompson CB. Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis? Nat Cell Biol 1: E209-E216, 1999.
37. Vieira HL, Boya P, Cohen I, El Hamel C, Haouzi D, Druillenec S, Belzacq AS, Brenner C, Roques B, and Kroemer G. Cell permeable BH3-peptides overcome the cytoprotective effect of Bcl-2 and Bcl-X(L). Oncogene 21: 1963-1977, 2002.
38. Vyssokikh MY, Zorova L, Zorov D, Heimlich G, Jurgensmeier JJ, and Brdiczka D. Bax releases cytochrome c preferentially from a complex between porin and adenine nucleotide translocator. Hexokinase activity suppresses this effect. Mol Biol Rep 29: 93-96, 2002.
39. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB, and Korsmeyer SJ. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292: 727-730, 2001.
40. White FA, Keller-Peck CR, Knudson CM, Korsmeyer SJ, and Snider WD. Widespread elimination of naturally occurring neuronal death in Bax-deficient mice. J Neurosci 18: 1428-1439, 1998.
41. Wolter KG, Hsu Y-T, Smith CL, Nechushtan A, Xi X-G, and Youle RJ. Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol 139: 1281-1292, 1997.
42. Wood DE and Newcomb EW Cleavage of Bax enhances its cell death function. Exp Cell Res 256: 375-382, 2000.
43. Yuan J and Yankner BA. Apoptosis in the nervous system. Nature 407: 802-809, 2000.
44. Zha J, Harada H, Osipov K, Jockel J, Waksman G, and Korsmeyer SJ. BH3 domain of BAD is required for heterodimerization with BCL-XL and proapoptotic activity. J Biol Chem 272: 24101-24104, 1997.
45. Zhou XM, Liu Y, Payne G, Lutz RJ, and Chittenden T. Growth factors inactivate the cell death promoter BAD by phosphorylation of its BH3 domain on Ser155. J Biol Chem 275: 25046-25051, 2000.
46. Zong WX, Lindston T, Ross AJ, MacGregor GR, and Thompson CB. BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev 15: 1481-1486, 2001.